BRPI0511258A - composições de fator de transferência encapsulado e métodos de uso - Google Patents

composições de fator de transferência encapsulado e métodos de uso

Info

Publication number
BRPI0511258A
BRPI0511258A BRPI0511258-3A BRPI0511258A BRPI0511258A BR PI0511258 A BRPI0511258 A BR PI0511258A BR PI0511258 A BRPI0511258 A BR PI0511258A BR PI0511258 A BRPI0511258 A BR PI0511258A
Authority
BR
Brazil
Prior art keywords
methods
transfer factor
compositions
encapsulated transfer
factor compositions
Prior art date
Application number
BRPI0511258-3A
Other languages
English (en)
Inventor
C Ramaekers D V M Joseph
Original Assignee
C Ramaekers D V M Joseph
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by C Ramaekers D V M Joseph filed Critical C Ramaekers D V M Joseph
Publication of BRPI0511258A publication Critical patent/BRPI0511258A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)

Abstract

COMPOSIçõES DE FATOR DE TRANSFERêNCIA ENCAPSULADO E MéTODOS DE USO. Composições que compreendem fator de transferência e/ou glicano, como glicano híbrido, revestido com um revestimento hidrofóbico ou lipídico. A composição pode ser combinada com substâncias nutrientes que incluem zinco, ácidos graxos essenciais, bactérias que geram ácido lático etc. Também são fornecido métodos para prevenção e tratamento de patologias animais que usam estas composições bem como métodos de fazê-las.
BRPI0511258-3A 2004-05-20 2005-05-17 composições de fator de transferência encapsulado e métodos de uso BRPI0511258A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US57311304P 2004-05-20 2004-05-20
US64936305P 2005-02-01 2005-02-01
US11/106,054 US20060073197A1 (en) 2004-05-20 2005-04-13 Encapsulated transfer factor compositions and methods of use
PCT/US2005/017316 WO2005112891A2 (en) 2004-05-20 2005-05-17 Encapsulated transfer factor compositions and methods of use

Publications (1)

Publication Number Publication Date
BRPI0511258A true BRPI0511258A (pt) 2007-11-27

Family

ID=35428821

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0511258-3A BRPI0511258A (pt) 2004-05-20 2005-05-17 composições de fator de transferência encapsulado e métodos de uso

Country Status (8)

Country Link
US (1) US20060073197A1 (pt)
EP (1) EP1750672A4 (pt)
JP (1) JP2007538090A (pt)
AU (1) AU2005244906A1 (pt)
BR (1) BRPI0511258A (pt)
CA (1) CA2567348A1 (pt)
MX (1) MXPA06013330A (pt)
WO (1) WO2005112891A2 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070128253A1 (en) * 2005-04-13 2007-06-07 Ramaekers Joseph C Encapsulated transfer factor compositions and methods of use
US6506413B1 (en) * 2001-04-30 2003-01-14 Joseph C. Ramaekers Compositions for treating animal diseases and syndromes
WO2006061021A1 (en) * 2004-12-10 2006-06-15 Nor-Feed A/S Natural antioxidative additive for feed and products used for humans
EP1962774B1 (en) * 2005-11-01 2014-01-01 Mount Sinai School of Medicine Growth control of oral and superficial microorganisms using gallium compounds
US20090053197A1 (en) * 2006-06-14 2009-02-26 Ramaekers Joseph C Transfer Factor Compositions and Methods
US9125874B2 (en) 2007-11-30 2015-09-08 The Ramaekers Family Trust Administration of transfer factor for improving reproductive health
US20090074751A1 (en) * 2007-09-18 2009-03-19 Ramaekers Nutrition, Inc. Growth factor fraction compositions and methods
EP2278984A4 (en) * 2007-11-30 2013-02-27 Ramaekers Family Trust COMPOSITIONS AND METHODS FOR ENHANCING FERTILITY
CN106511415A (zh) * 2010-05-24 2017-03-22 Nse产品公司 用于抵抗衰老作用的口服制剂
WO2016085932A1 (en) * 2014-11-24 2016-06-02 Nutrition Physiology Company, Llc Lactic acid bacterium as pet dietary supplement

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237118A (en) * 1972-03-06 1980-12-02 Howard Alan N Dietary supplement and dietary methods employing said supplement for the treatment of obesity
US4220666A (en) * 1978-02-03 1980-09-02 Desert Merchandising, Inc. Sucrose-invert sugar protein product and method of manufacture
US4435384A (en) * 1982-04-30 1984-03-06 Viragen, Inc. Transfer factor composition and skin treatment
US4816563A (en) * 1983-11-25 1989-03-28 Amtron, Inc. Process for obtaining transfer factor from colostrum, transfer factor so obtained and use thereof
US4739046A (en) * 1985-08-19 1988-04-19 Luzio Nicholas R Di Soluble phosphorylated glucan
ES2052496T3 (es) * 1985-11-25 1994-07-16 Ghen Corp Sustancia que contiene anticuerpo especifico obtenida de huevos y metodo para su produccion y uso.
JPH0789876B2 (ja) * 1987-06-19 1995-10-04 日本曹達株式会社 反芻動物用飼料添加物
US5211956A (en) * 1988-05-19 1993-05-18 Sanwa Kagaku Kenkyusho Co., Ltd. Pharmaceutical compositions containing phytic acid or its salts
US5234698A (en) * 1988-07-05 1993-08-10 Fahim Mostafa S Intraprostatic injection of zinc ions for treatment of inflammatory conditions and benign and malignant tumors of the prostate
WO1990006060A1 (fr) * 1988-12-07 1990-06-14 San-Ei Chemical Industries, Ltd. Procede de preparation d'un concentre de lait/mineraux et boisson mineralisee
US5064674A (en) * 1989-01-13 1991-11-12 Immunopath Profile, Inc. Hypoallergenic milk products and process of making
JPH05508847A (ja) * 1990-07-02 1993-12-09 ナシヨナル・ジユーイツシユ・センター・フオー・イミユノロジー・アンド・レスピラトリー・メデイシン 伝達因子および使用方法
JP3007127B2 (ja) * 1990-10-09 2000-02-07 中外製薬株式会社 Ｈｓｖ経口ワクチン及びその製造方法
US5190775A (en) * 1991-05-29 1993-03-02 Balchem Corporation Encapsulated bioactive substances
FI91166C (fi) * 1991-10-17 1994-05-25 Valio Biotuotteet Oy Ternimaitofraktio, menetelmä sen valmistamiseksi ja sen käyttö kasvualustojen täydennysaineena
US5425944A (en) * 1992-10-27 1995-06-20 Harich; Jakob Antimicrobial grapefruit extract
EP0640348A1 (en) * 1993-07-26 1995-03-01 Akzo Nobel N.V. Oil-based and water-based adjuvant mixture
US5728352A (en) * 1994-11-14 1998-03-17 Advanced Care Products Disposable electronic diagnostic instrument
US6770278B1 (en) * 1994-12-02 2004-08-03 Central Biomedia, Inc. Methods of making and using immunoglobulin (Ig) compositions
US5833948A (en) * 1995-06-15 1998-11-10 Bracco Research S.A. Blood-pool imaging composition comprising micelles containing a lipophilic chelating agent and a non-ionic surfactant
US5883224A (en) * 1996-04-19 1999-03-16 Cytokine Sciences, Inc. Characterization of transfer factors and methods of use
JPH10113130A (ja) * 1996-10-09 1998-05-06 Ajinomoto Co Inc 反すう動物用飼料添加組成物
US5993221A (en) * 1997-05-01 1999-11-30 Beth Israel Deaconess Medical Center, Inc. Dietary formulation comprising arachidonic acid and methods of use
AU7780598A (en) * 1997-06-05 1998-12-21 Neuroimmuno Therapeutics Research Foundation Pharmaceutical composition containing transfer factor for treatment of inflam matory bowel disease and regressive behavioural disorder
RU2125460C1 (ru) * 1997-11-17 1999-01-27 Закрытое акционерное общество научно-производственная фирма "Новь" Биостимулирующее средство
US6153320A (en) * 1999-05-05 2000-11-28 International Business Machines Corporation Magnetic devices with laminated ferromagnetic structures formed with improved antiferromagnetically coupling films
US20020044942A1 (en) * 2000-09-18 2002-04-18 Chisolm Biological Laboratory, Llc Transfer factor composition and process for producing same
US6468534B1 (en) * 2000-09-21 2002-10-22 4Life Research, Lc Methods for obtaining transfer factor from avian sources, compositions including avian-generated transfer factor, and methods of use
AU2002243267A1 (en) * 2000-10-27 2002-06-24 Mannatech, Inc. Dietary supplement compositions
US20070128253A1 (en) * 2005-04-13 2007-06-07 Ramaekers Joseph C Encapsulated transfer factor compositions and methods of use
US6506413B1 (en) * 2001-04-30 2003-01-14 Joseph C. Ramaekers Compositions for treating animal diseases and syndromes
US6939864B1 (en) * 2001-07-09 2005-09-06 Purdue Research Foundation Animal feed compositions and methods of using the same
JP4274748B2 (ja) * 2002-06-25 2009-06-10 株式会社Ａｄｅｋａ βグルカン含有油脂組成物を用いたベーカリー製品
CA2490452C (en) * 2002-06-25 2013-05-28 Asahi Denka Co., Ltd. .beta.-glucan-containing fat and oil composition and novel microorganism capable of producing .beta.-glucan
US20090053197A1 (en) * 2006-06-14 2009-02-26 Ramaekers Joseph C Transfer Factor Compositions and Methods
US20090074751A1 (en) * 2007-09-18 2009-03-19 Ramaekers Nutrition, Inc. Growth factor fraction compositions and methods

Also Published As

Publication number Publication date
US20060073197A1 (en) 2006-04-06
WO2005112891A2 (en) 2005-12-01
EP1750672A2 (en) 2007-02-14
CA2567348A1 (en) 2005-12-01
WO2005112891A3 (en) 2006-05-04
MXPA06013330A (es) 2007-04-16
JP2007538090A (ja) 2007-12-27
EP1750672A4 (en) 2010-12-29
AU2005244906A1 (en) 2005-12-01

Similar Documents

Publication Publication Date Title
WO2008137758A3 (en) Amino acid lipids and uses thereof
BR112014011251A2 (pt) alimentos palatáveis para animais de estimação e métodos para aprimorar a palatabilidade de alimentos para animais de estimação
DK1390049T3 (da) Sammensætninger til behandling af dyresygdomme og -syndromer omfattende transferfaktor
EP2407475A3 (en) Synthetic Bile Acid Composition, Method, and Preparation
WO2008008770A3 (en) 6, 9-disubstituted purine derivatives and their use for treating skin
CL2008003854A1 (es) Compuestos derivados de 2-bencilpiridazinona, inhibidores, reguladores y/o moduladores de met-quinasa; composicion farmaceutica; procedimiento de preparacion; y uso en el tratamiento de un tumor solido, de la sangre o del sistema inmune; kit farmaceutico que comprende una cantidad de dicho compuesto.
BRPI0713357A2 (pt) Inibidores de proteína tirosina fosfatase humana e método de utilização.
BRPI0713349A2 (pt) Inibidores de proteína tirosina fosfatase humana e métodos de utilização
BRPI0414096A (pt) sistema lipìdico e métodos de uso
WO2007101007A8 (en) Aryl sulfonyl heterocycles
BR112012006283A2 (pt) formulação de adamts13 estabilizada, método para fabricar uma formulação de adamts13 estabilizada, kit, e métodos para tratar ou prevenir uma doença e para tratar ou previnir um enfarte
BRPI0511258A (pt) composições de fator de transferência encapsulado e métodos de uso
AR064254A1 (es) Maiz extraido con solvente
ZA200805731B (en) Compositions and method for promoting fat loss
CL2009000246A1 (es) Compuestos derivados de 1h-imidazo[4,5-b]piridin-2-ol; moduladores de la contraccion sarcomero; composicion farmaceutica que comprende; kit farmaceutico; y uso en el tratamiento de enfermedades neuromusculares, tales como atrofia, fatiga, claudicacion, en entre otras.
MX2010005702A (es) Esteres butirico-formico mixtos de polisacaridos acidos, y su preparacion y uso como cosmeticos para la piel.
WO2010019914A3 (en) Anti-arrhythmia agents, methods of their use, methods for their identification, and kits thereofre
BRPI0519070A2 (pt) composiÇço de fator de crescimento de queratinàcito liofilizada, mÉtodos para preparar um fator de crescimento de queratinàcito liofilizado, e para tratar uma doenÇa, e, kit para preparar uma composiÇço farmacÊutica aquosa
AR048938A1 (es) Cepas de levadura que producen colesterol y sus aplicaciones
MA34291B1 (fr) Compositions et méthodes de diagnostic et de traitement d'une tumeur
BR0316782A (pt) Produto de leite fermentado, processo para preparação de um produto de leite fermentado e uso da linhagem cnrz 244 de lactobacillus helveticus
DE502006004182D1 (de) Substituierte 5,6,7,8-tetrahydro-imidazoä1 ,2-aüpyridin-2-ylamin-verbindungen und deren verwendung zur herstellung von arzneimitteln
NO20082848L (no) Farmasoytisk formulering for behandling av osteoartritt inneholdende klodronsyre og hyaluronsyre
WO2005084368A3 (en) Heteroalkyl-substituted biphenyl-4-carboxylic acid arylamide analogues
EP1845941A4 (en) SYRUP COMPOSITION CONTAINING DEXIBUPROPENE AS ACTIVE INGREDIENT AND PROCESS FOR PREPARING THE SAME

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE AO NAO RECOLHIMENTO DA 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2204 DE 02/04/2013.